Aster Capital Management (Difc) LTD Celldex Therapeutics, Inc. Transaction History
Aster Capital Management (Difc) LTD
- $198 Billion
- Q3 2025
A detailed history of Aster Capital Management (Difc) LTD transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Aster Capital Management (Difc) LTD holds 1,014 shares of CLDX stock, worth $25,907. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,014Holding current value
$25,907% of portfolio
0.01%Shares
3 transactions
Others Institutions Holding CLDX
# of Institutions
204Shares Held
68.2MCall Options Held
227KPut Options Held
225K-
Kynam Capital Management, LP Princeton, NJ6.1MShares$156 Million13.34% of portfolio
-
Wellington Management Group LLP Boston, MA5.8MShares$148 Million0.03% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$120 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.95MShares$101 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct3.89MShares$99.5 Million0.2% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $1.2B
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...